The research team, led by Li Yang and Xiaoqi Jiang of Guizhou University of Traditional Chinese Medicine along with colleagues from hospitals and pharmaceutical partners across Guizhou, undertook one of the most ambitious chemical surveys of the species to date. They collected E. sagittatum samples from 41 geographic origins spanning nine Chinese provinces, measuring the contents of six individual flavonol glycosides as well as total flavonol glycosides and total flavonoids in three separate plant organs: roots, stems, and leaves. That organ-by-organ, site-by-site design is what gives the study its power, because it separates what the plant is from where the plant grew.

The first headline finding concerns anatomy. Leaves and roots emerged as the primary accumulation organs for flavonoid compounds, while stems consistently showed the lowest levels. Even more striking was the division of labor between the two rich organs. Leaves preferentially accumulated most of the characteristic flavonol glycosides, including epimedin A, epimedin B, icariin, icariside I, and baohuoside I. Icariin in particular is the compound most closely associated with the pharmacological activity attributed to the species. Roots, by contrast, stored higher levels of epimedin C and of total flavonol glycosides overall.

That split has practical consequences. Chinese Pharmacopoeia standards designate the leaf as the official medicinal part of E. sagittatum, and the new data provide chemical justification for that choice. If the bioactive compounds that define the drug’s quality concentrate preferentially in leaves, then harvesting leaves rather than whole plants delivers the desired chemistry while potentially leaving root systems and plants in the ground. For a wild-collected species facing pressure from demand, that distinction between tradition and sustainability becomes genuinely important.

The analytical heart of the study lies in how the team connected chemistry to environment. They assembled three categories of explanatory variables: soil properties such as nutrient concentrations and organic matter, climatic variables including temperature and precipitation, and spatial factors capturing geography itself. These were then integrated with the phytochemical measurements using a battery of statistical tools: principal component analysis to summarize overall chemical variation, correlation analysis to flag simple associations, and redundancy analysis to quantify how much of the chemical variation each environmental factor explains. Finally, co-kriging spatial prediction was used to extrapolate the findings across the landscape, producing maps of where high-quality plants are most likely to grow.

The results revealed something subtle: the dominant environmental drivers of flavonoid accumulation differ depending on which organ you examine. In roots, the major factors were available phosphorus, altitude, and soil organic matter. In stems, total potassium and annual precipitation took the lead. In leaves, the organs that matter most medicinally, the key determinants were annual precipitation, mean annual temperature, and altitude. In other words, there is no single recipe for a medicinal E. sagittatum plant; each tissue responds to its own combination of climate and soil chemistry.

From a plant physiology standpoint, these organ-specific patterns make biological sense. Roots directly experience the soil solution, so phosphorus availability and organic matter content shape what the underground tissue can take up and store. Leaves, as the photosynthetic engine of the plant, integrate the aboveground environment, and flavonoid biosynthesis in foliage is well known to respond to temperature, light, and water status. Precipitation and temperature emerging as leaf-level drivers is consistent with the broader understanding that flavonoids often function as stress-protective metabolites, whose production shifts as plants contend with their thermal and hydrological conditions.

The spatial modeling translated these relationships into geography. The co-kriging predictions identified eastern Guizhou, southwestern Hubei, northeastern Guangxi, and parts of Jiangxi as regions with high potential for producing high-quality E. sagittatum resources. These areas, clustered in the subtropical mountains of central-southern China, combine the climatic and edaphic conditions associated with elevated flavonoid levels. The concept of geo-authenticity, the traditional Chinese medicine idea that certain herbs are genuinely superior when grown in their authentic native regions, thus gains a quantitative, testable foundation. What was once empirical lore passed down through generations of herbalists now appears as measurable ecological differentiation.

The implications ripple outward in several directions. For cultivators and the pharmaceutical industry, knowing which environmental levers influence leaf flavonoid content opens the door to site selection and agronomic management: choosing cultivation zones with the right precipitation regimes, temperatures, and altitudes, or adjusting soil conditions where feasible. For breeders, the identification of naturally high-quality provenances provides a starting point for elite germplasm selection. For conservation planners, the mapped suitability surfaces highlight where wild genetic resources deserve protection before habitat loss or overharvesting erodes them.

There are also broader lessons for medicinal plant science in general. Most quality assessments of herbal medicines examine a single organ from a limited set of sources, which can mask the kind of organ-specific, environment-dependent variation documented here. By sampling three organs across 41 origins and formally disentangling soil, climate, and spatial effects, the study offers a template for how ecological authentication could be applied to other traditional medicinal species. As global demand for plant-derived pharmaceuticals and supplements grows, approaches like this one, blending analytical chemistry, ecology, and spatial statistics, may become essential tools for ensuring that the next generation of herbal medicines is both potent and sustainably produced. For E. sagittatum, at least, science now knows not just what makes the plant medicinal, but where the mountain, the rain, and the soil conspire to make it best.

Subject of Research: Environmental drivers of flavonoid accumulation and geo-authenticity in Epimedium sagittatum

Article Title: Multi-environment evaluations across ecological regions reveals climate and soil effects on flavonoids and flavonol glycosides contents in traditional Chinese medicinal plant Epimedium sagittatum and its geo-authenticity spatial patterns

Article References: Multi-environment evaluations across ecological regions reveals climate and soil effects on flavonoids and flavonol glycosides contents in traditional Chinese medicinal plant Epimedium sagittatum and its geo-authenticity spatial patterns. (n.d.). https://doi.org/10.1186/s12870-026-09882-z

Image Credits: AI Generated

DOI: 10.1186/s12870-026-09882-z

Keywords: Epimedium sagittatum, flavonoids, flavonol glycosides, icariin, geo-authenticity, traditional Chinese medicine, soil properties, climate, altitude, spatial prediction, plant ecology, medicinal plants

Gastric cancer remains a formidable clinical challenge. Despite advances in surgery, chemotherapy, targeted agents, and immunotherapy, patients with advanced disease continue to face poor prognosis, and the disease is driven by interconnected processes including uncontrolled proliferation, invasion, metastasis, angiogenesis, immune escape, and remodeling of the tumor microenvironment. Icariin has previously shown anti-inflammatory, antioxidant, immunomodulatory, and antitumor properties across several cancer models, and earlier studies suggested it could influence malignant behaviors in gastric cancer cells. Yet because natural compounds typically engage dozens of targets simultaneously, the key molecular mediators of icariin’s effects in gastric cancer had never been systematically clarified. The new study set out to close that gap using an integrated computational and experimental framework.

The team began with classic network pharmacology. Potential icariin targets were retrieved from the TCMSP database and converted to official gene symbols via UniProt, while gastric cancer-related genes were defined as the union of differentially expressed genes and co-expression modules associated with the disease in the TCGA-STAD cohort. Differential expression analysis with limma revealed marked transcriptional differences between tumor and normal tissue, and weighted gene co-expression network analysis identified a turquoise module—enriched for cell cycle, DNA replication, p53 signaling, and viral carcinogenesis pathways—as most strongly correlated with the gastric cancer phenotype. Intersecting icariin targets with disease genes yielded 24 overlapping candidates, and univariate Cox regression singled out NOX4 as significantly associated with patient survival.

Follow-up analyses across large public datasets strengthened the case for NOX4’s clinical relevance. Pan-cancer profiling showed aberrant NOX4 expression in multiple tumor types, with marked upregulation in gastric cancer. In three independent cohorts—GSE15497, GSE84437, and GSE26253—high NOX4 expression consistently predicted poorer overall survival. Gene set enrichment analysis revealed that tumors with high NOX4 expression were enriched for progression-related programs such as ECM-receptor interaction, pathways in cancer, focal adhesion, and TGF-beta signaling, whereas low-NOX4 tumors leaned toward metabolic pathways including fatty acid degradation, pyruvate metabolism, and drug metabolism via cytochrome P450. NOX4 expression also rose with pathological grade and clinical stage, and a nomogram integrating NOX4 with clinical variables showed good calibration for predicting one-, three-, and five-year survival.

The study’s most striking single-cell insight came from an analysis of 142,053 cells drawn from 40 gastric tissue samples—29 tumors and 11 normal specimens—in dataset GSE183904. After quality control, Harmony-based batch correction, and clustering, cells resolved into 38 clusters spanning 11 major populations, including malignant epithelial cells, T and NK cells, macrophages, endothelial cells, fibroblasts, and myofibroblasts. InferCNV analysis separated epithelial cells into high- and low-copy-number-variation groups, confirming malignant heterogeneity, while CytoTRACE revealed diverse differentiation states across the microenvironment. Crucially, NOX4 expression was concentrated almost exclusively in endothelial cells, prompting the researchers to split this compartment into NOX4-positive and NOX4-negative subpopulations with partially distinct transcriptional identities.

These two endothelial states differed in ways that matter for tumor biology. NOX4-positive endothelial cells were enriched for angiogenesis, focal adhesion, integrin signaling, ECM-receptor interaction, PI3K-Akt signaling, and actin cytoskeleton regulation, along with elevated oxidative phosphorylation, glycolysis, and glutathione metabolism. NOX4-negative endothelial cells instead showed immune-related features such as antigen processing and presentation. Transcription factor analysis via SCENIC found higher ELK3, JUN, and JUNB activity in the NOX4-positive subset. CellChat-based communication mapping showed that NOX4-positive endothelial cells interacted more broadly with macrophages, fibroblasts, dendritic cells, and T/NK cells, with ligand-receptor axes involving SPP1, MDK, MIF, and ANGPTL2 linking them to both normal and malignant epithelial cells. A gene signature derived from this subset predicted poor survival across the TCGA-STAD, GSE84437, and GSE84433 cohorts, and consensus clustering based on the signature reproducibly separated patients into two subtypes, with the high-score cluster showing worse outcomes and enrichment for epithelial-mesenchymal transition, angiogenesis, IL6-JAK-STAT3, and inflammatory response pathways.

To translate the signature into a practical tool, the researchers built a five-gene prognostic model—comprising SPIRE1, PLCH1, KCNS3, SLC27A2, and GRP—using LASSO-Cox regression on genes shared across the three cohorts. The risk score stratified patients into high- and low-risk groups with significantly different survival in all cohorts, showed moderate time-dependent ROC performance for one-, three-, and five-year survival, and remained prognostic in multivariate models adjusting for clinicopathological variables. Notably, when the five model genes were excluded from the NOX4-positive endothelial signature, the recalculated score still correlated positively with the risk score, indicating that the model captures a broader transcriptional program of this endothelial state rather than riding on gene overlap alone. High-risk tumors also displayed lower immune scores, higher stromal scores, and differential expression of immune checkpoints and related molecules including LAG3, CD274 (PD-L1), CD276, and CD80.

Computational and wet-lab experiments then probed the icariin–NOX4 connection directly. Molecular docking using AutoDock Vina and Discovery Studio placed icariin within the predicted NOX4 binding pocket, with potential hydrogen bonds to Ser576 and Trp377, and a 100-nanosecond molecular dynamics simulation in GROMACS showed the complex settling into a stable conformation with limited ligand drift. In AGS gastric adenocarcinoma cells, icariin reduced viability in a concentration-dependent manner with an IC50 of 124.7 micromolar. Quantitative PCR and western blotting showed dose-associated reductions in NOX4 mRNA and protein, and DCFH-DA fluorescence imaging revealed lowered intracellular reactive oxygen species after treatment. The authors are careful to frame these results as associative: the docking evidence is predictive rather than proof of physical binding, the IC50 exceeds concentrations generally achievable in vivo, and icariin is a multi-target compound, so NOX4 should be viewed as a candidate node rather than a confirmed sole mediator.

Limitations temper the excitement but chart a clear path forward. Validation rested on a single cell line, with no animal models or independent clinical tissue testing; ROS measurements were semi-quantitative and would benefit from flow cytometry; and the prognostic model is best understood as a transcriptional surrogate of the NOX4-positive endothelial phenotype. Even so, the study demonstrates the power of stacking network pharmacology on multi-omics and single-cell foundations to move beyond target-list speculation toward mechanistically grounded hypotheses. If genetic perturbation experiments and direct binding assays confirm the icariin–NOX4 axis, the findings could open a route to icariin-based functional food strategies aimed at NOX4/ROS signaling in gastric cancer prevention—and elevate an ancient medicinal herb’s active ingredient into a modern redox-directed research program.

Subject of Research: Multi-omics and single-cell identification of NOX4 as an icariin-associated oxidative stress regulatory node in gastric cancer

Article Title: Integrated Multi‐Omics and Single‐Cell Analyses Implicate NOX4 as an Icariin‐Associated Oxidative Stress Regulatory Node in Gastric Cancer

Article References: Integrated Multi‐Omics and Single‐Cell Analyses Implicate NOX4 as an Icariin‐Associated Oxidative Stress Regulatory Node in Gastric Cancer. (n.d.). https://doi.org/10.1002/fsn3.72390

Image Credits: AI Generated

DOI: 10.1002/fsn3.72390

Keywords: icariin, NOX4, gastric cancer, oxidative stress, network pharmacology, single-cell RNA sequencing, reactive oxygen species, tumor microenvironment, endothelial cells, molecular docking, prognostic model, Epimedium